Formoterol superfine formulation

Details for Australian Patent Application No. 2003222753 (hide)

Owner Chiesi Farmaceutici S.p.A.

Inventors Church, Tanya Kathleen; Lewis, David Andrew; Davies, Rebecca Jaine; Brambilla, Gaetano; Ferraris, Alessandra; Ganderton, David; Meakin, Brian John

Agent Lord and Company

Pub. Number AU-B-2003222753

PCT Number PCT/EP03/01964

PCT Pub. Number WO2003/074024

Priority 02004786.6 01.03.02 EP; 02023589.1 23.10.02 EP

Filing date 26 February 2003

Wipo publication date 16 September 2003

Acceptance publication date 17 April 2008

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 31/00 (2006.01)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 11/16 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 02004786.6 01.03.02 EP; 02023589.1 23.10.02 EP

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003222753

17 April 2008 Application Accepted

  Published as AU-B-2003222753

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003222754-FIREPROOF HOUSING

2003222752-METHOD FOR SOLDERING ALUMINUM